C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
195/1.22, 195/1.
C12N 15/15 (2006.01) C07K 14/81 (2006.01) A61K 38/00 (2006.01)
Patent
CA 1341339
The invention is directed to an Arg-Serpin human plasminogen activator inhibitor designated PAI-2. This protein is prepared via recombinant DNA means. The invention also includes other serpins which can be made by amino acid substitutions or deletions in conserved regions of PAI-1 and PAI-2. The proteins of the invention can be used to inhibit, or at least modulate, human plasminogen activator activity in a variety of physiological conditions, e.g., fibrinolysis, tumor metastasis, and tumor growth.
556827
Auron Philip E.
Webb Andrew C.
Macrae & Co.
New England Medical Center Hospitals Inc.
Wellesley College
LandOfFree
Arg-serpin human plasminogen activator inhibitor designated... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Arg-serpin human plasminogen activator inhibitor designated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arg-serpin human plasminogen activator inhibitor designated... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1314584